MELA Sciences to Provide Corporate Overview at the Craig-Hallum Capital Group's 2014 Alpha Select Conference

09/17/2014

Rose Crane, CEO of MELA Sciences, will provide a corporate overview at the Craig-Hallum Capital Group's 2014 Alpha Select Conference in New York City.

Crane will discuss the latest FDA Pre-Market Approval of the MelaFind® System.

To learn more go to: www.melafind.com

Register

We're glad to see you're enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free